Through vasoconstriction, VEGFR-2 inhibitors can reduce the cerebral blood flow, and it is well known that vascular dementia is associated with reduced cerebral blood flow, particularly in the frontal lobe (Starkstein et al., 1996). This evidence concerns the gene KDR and vascular dementia.